Background Postpartum haemorrhage (PPH) is the leading cause of maternal mortality
worldwide. Prophylactic uterotonic agents can prevent PPH, and are routinely …

Background Prostaglandins have mainly been used for postpartum haemorrhage (PPH)
when other measures fail. Misoprostol, a new and inexpensive prostaglandin E1 analogue …

Background Postpartum haemorrhage is a leading cause of maternal morbidity and
mortality. Active management of the third stage of labour, including use of a uterotonic agent …

Postpartum hemorrhage (PPH) is the leading cause of death related to pregnancy
worldwide. Most deaths resulting from PPH are preventable. Physicians, nurses, midwives …

Background Previous research has shown that the prophylactic use of uterotonic agents in
the third stage of labour reduces postpartum blood loss and moderate to severe postpartum …

Postpartum hemorrhage (PPH) remains a significant contributor to maternal morbidity and
mortality throughout the world. The majority of research on this topic has focused on efforts …

Despite the strong interest of international health agencies, worldwide maternal mortality
has not declined substantially over the past 10 years. Postpartum hemorrhage (PPH) is the …

OBJECTIVE: To review published literature on misoprostol for women's health indications to
provide a synthesis of available information and highlight areas in need of additional …

BACKGROUND Postpartum haemorrhage (PPH) is the leading cause of maternal mortality
worldwide. Prophylactic uterotonic drugs can reduce blood loss and are routinely …

Postpartum haemorrhage (PPH) is the leading cause of maternal death worldwide. In the
developing countries, it is responsible for the death of about 125 000 women each year …